#ChemPass_AI
AgPlenus Reports Breakthroughs in Fungicide Innovations to Combat Wheat Disease#Israel#Rehovot#Evogene#AgPlenus#ChemPass_AI
AgPlenus Reports Breakthroughs in Fungicide Innovations to Combat Wheat Disease
AgPlenus Ltd. has announced key advancements in its fungicide discovery programs aimed at tackling resistant fungal diseases in wheat crops.
third-news.com
November 17, 2026 at 12:37 PM
Evogene Targets Acute Graft-Versus-Host Disease with Innovative AI-Driven Drug Discovery#Israel#Rehovot#Evogene#ChemPass_AI#aGvHD
Evogene Targets Acute Graft-Versus-Host Disease with Innovative AI-Driven Drug Discovery
Evogene Ltd. announces targeting acute graft-versus-host disease in its AI-driven drug discovery program, aiming for a novel treatment approach.
third-news.com
October 28, 2026 at 12:54 PM
Evogene to Showcase Innovative Solutions at AI Drug Discovery Roadshow on the U.S. East Coast#Israel#Rehovot#Drug_Discovery#Evogene#ChemPass_AI
Evogene to Showcase Innovative Solutions at AI Drug Discovery Roadshow on the U.S. East Coast
Evogene Ltd. is set to participate in an AI Drug Discovery Roadshow from November 2-5, 2026, aimed at enhancing collaborations in drug development.
third-news.com
October 20, 2026 at 12:30 PM
Evogene and Pure Capital Group Forge Agreement for Collaborative Future and New Board Structure#Israel#Rehovot#Evogene#ChemPass_AI#Pure_Capital_Group
Evogene and Pure Capital Group Forge Agreement for Collaborative Future and New Board Structure
Evogene Ltd. enters a strategic agreement with Pure Capital Group, resolving disputes and restructuring its board to enhance stability and focus on innovation.
third-news.com
October 6, 2026 at 8:04 PM
Evogene's Strategic Response to Shareholder Dissent: A Path to Success#Israel#Rehovot#shareholder_activism#Evogene#ChemPass_AI
Evogene's Strategic Response to Shareholder Dissent: A Path to Success
Evogene Ltd. addresses shareholder concerns with a clear path ahead, showcasing its transformative progress and strategies for future growth.
third-news.com
August 31, 2026 at 12:15 PM
Evogene Partners with Google Cloud to Revolutionize AI in Small Molecule Discovery and Optimization#Israel#Google_Cloud#Rehovot#Evogene#ChemPass_AI
Evogene Partners with Google Cloud to Revolutionize AI in Small Molecule Discovery and Optimization
Evogene Ltd. reaches a significant collaboration milestone with Google Cloud, enhancing ChemPass AI™ for advanced small molecule discovery aimed at revolutionizing pharmaceuticals.
third-news.com
June 24, 2026 at 12:31 PM
Evogene Ltd.'s First Quarter 2026 Financial Review and Strategic Updates#Israel#Rehovot#AgPlenus#Evogene_Ltd#ChemPass_AI
Evogene Ltd.'s First Quarter 2026 Financial Review and Strategic Updates
Evogene Ltd. has reported its financial outcomes for Q1 2026, highlighting strategic advancements in AI-driven small-molecule discovery and collaborations.
third-news.com
May 20, 2026 at 11:12 AM
Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025#Israel#financial_results#Rehovot#Evogene#ChemPass_AI
Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025
Evogene Ltd. announces financial results for Q4 and full year 2025, highlighting a strategic focus on its ChemPass AI™ platform for drug discovery.
third-news.com
March 5, 2026 at 12:19 PM
Evogene's Transformative Strategy to Create Long-Term Value for Shareholders#Israel#Rehovot#Evogene#ChemPass_AI#Ofer_Haviv
Evogene's Transformative Strategy to Create Long-Term Value for Shareholders
Discover Evogene's significant advancements and strategic transformation, focusing on long-term value creation in pharmaceuticals and agriculture.
third-news.com
February 25, 2026 at 1:25 PM
Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth#Israel#Rehovot#Warrant_Inducement#Evogene#ChemPass_AI
Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth
Evogene Ltd. has announced a warrant inducement agreement generating $3.4 million in gross proceeds to support its innovative efforts in chemistry.
third-news.com
February 10, 2026 at 6:27 PM
Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development#Israel#Google_Cloud#Rehovot#Evogene#ChemPass_AI
Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development
Evogene extends its partnership with Google Cloud, integrating AI agents into ChemPass AI™ to enhance small-molecule discovery, promising quicker pharmaceutical development.
third-news.com
February 10, 2026 at 1:36 PM
Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board#Israel#Rehovot#Evogene#ChemPass_AI#John_Irwin
Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board
Evogene Ltd. enhances its scientific team by announcing the appointment of two renowned professors. This move aims to support its innovative ChemPass AI™.
third-news.com
February 9, 2026 at 1:12 PM
Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth#Israel#Rehovot#Evogene#ChemPass_AI#Dr._Nissan
Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth
Dr. Olga Nissan has been appointed VP of Business Development at Evogene, bringing extensive expertise in biotech and pharma to accelerate innovation.
third-news.com
December 30, 2025 at 12:02 PM
Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities#Israel#Rehovot#Evogene#Lavie_Bio#ChemPass_AI
Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities
Evogene has shared its second quarter 2025 financial results, revealing significant strategic changes and future prospects in pharmaceuticals and agriculture.
third-news.com
August 19, 2025 at 11:16 AM